ERYTECH Pharma (NASDAQ:ERYP – Get Rating) and Amgen (NASDAQ:AMGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings. Institutional & Insider Ownership 4.8% of ERYTECH Pharma shares are owned […]
Amgen (NASDAQ:AMGN – Get Rating) and ERYTECH Pharma (NASDAQ:ERYP – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 75.5% of Amgen shares are owned by […]
ERYTECH Pharma (NASDAQ:ERYP – Get Rating) and Surface Oncology (NASDAQ:SURF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 4.8% of ERYTECH Pharma shares […]
ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Rating) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 33,900 shares, a decline of 11.0% from the March 15th total of 38,100 shares. Based on an average trading volume of 33,900 shares, the days-to-cover ratio is […]
ERYTECH Pharma (NASDAQ:ERYP – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Earnings & Valuation This table compares ERYTECH Pharma and […]